| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972915 | The Journal of Heart and Lung Transplantation | 2007 | 7 Pages |
Abstract
Pediatric lung transplant recipients <3 years of age are at increased risk of adenovirus pneumonia early after transplantation. Cidofovir, when used in the modified dosing regimen and in combination with IVIg and renal protection measures, is a safe and potentially effective treatment option for adenovirus pneumonia in lung transplant recipients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Minh L. MD, George B. MD, Sheldon L. MD, Megan K. MD, Marc G. MD, E. Dean MD, Jeffrey S. MD, Okan MD,